Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06348108
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-04
First Post:
2024-03-29
Brief Title:
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Sponsor:
Thomas Martin MD
Organization:
University of California San Francisco
Organization Data
Organization:
University of California San Francisco
Class:
OTHER
Study ID:
232514
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Thomas Martin MD
Lead Sponsor Class:
OTHER
Responsible Party:
Thomas Martin MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of California San Francisco
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen Research Development LLC | INDUSTRY |
| Bristol-Myers Squibb | INDUSTRY |